Recommendation of the President – Kaftrio (ivacaftor + tezacaftor + elexacaftor)
On 3 November 2024, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 119/2024 on the evaluation of the drug Kaftrio (ivacaftor + tezacaftor + elexacaftor) used in combination with Kalydeco (ivacaftor) under the drug program “Treatment of patients with cystic fibrosis (ICD-10: E84)”
Publication in Public Information Bulletin (BIP) >>